Non-erosive reflux disease and atypical gastro-oesophageal reflux disease manifestations: Treatment results

Drugs

Volumn 66, Issue SUPPL. 1, 2006, Pages 7-13

  Galmiche, Jean Paul ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACID; CORTICOSTEROID; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ASTHMA; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; COUGHING; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE EXACERBATION; DOSE RESPONSE; DRUG EFFECT; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGITIS; META ANALYSIS; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PH MEASUREMENT; QUALITY OF LIFE; REFLUX ESOPHAGITIS; SYSTEMATIC REVIEW; THORAX PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE;

ASTHMA; CHEST PAIN; COUGH; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNGITIS;

EID: 33645527325     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666991-00004     Document Type: Conference Paper

References (24)

1. Crawley JA, Maclin Schmitt C. How satisfied are chronic heartburn sufferers with their prescription medications? Results of the patient unmet needs survey. J Clin Outcomes Manag 2000; 7: 29-34
2. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44 suppl. 2: S1-6
3. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190-200
4. Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease - an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18: 767-76
5. Wiklund I. Review of the quality of life and burden of illness in gastroesophageal reflux disease. Dig Dis 2004; 22: 108-14
6. Dean BB, Gano AD Jr, Knight K, et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004; 2: 656-64
7. Shay S, Sifrim D, Tutuian R, et al. Multichannel intraluminal impedance (MII) in the evaluation of patients with persistent GERD symptoms despite proton pump inhibitors (PPI): a multicenter study [Abstract]. Gastroenterology 2003; 124 suppl. 1: A-537
8. Fass R, Ofman JJ. Gastroesophageal reflux disease - should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97: 1901-9
9. Pace F, Bollani S, Molteni P, et al. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD) - a reappraisal 10 years on. Dig Liver Dis 2004; 36: 111-5
10. Ruigomez A, Garcia Rodriguez LA, Wallander MA, et al. Natural history of gastro-oesophageal reflux disease diagnosed in general practice. Aliment Pharmacol Ther 2004; 20: 751-60
11. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extra-oesophageal manifestations in gastro-oesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003; 17: 1515-20
12. Sifrim D, Dupont L, Blondeau K, et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 2005; 54: 449-54
13. Poe RH, Kallay MC. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 2003; 123: 679-84
14. Kiljander TO, Salomaa ER, Hietanen EK, et al. Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000; 16: 633-8
15. Ours TM, Kavuru MS, Schilz RJ, et al. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131-8
16. Field SK, Sutherland LR. Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux? a critical review of the literature Chest 1998; 114: 275-83
17. Gibson PG, Henry RL, Coughlan JL. Gastro-oesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003; (2): CD001496
18. Littner MR, Leung FW, Ballard ED II, et al. Effects of 24 weeks of lansoprazole therapy on asthma symptoms, exacerbations, quality of life, and pulmonary function in adult asthmatic patients with acid reflux symptoms. Chest 2005; 128: 1128-35
19. El-Serag HB, Lee P,Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-83
20. Vaezi MF, Richter J, Stasney CR, et al. A randomized, double-blind, placebo-controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux [Abstract]. Gastroenterology 2004; 126 4 suppl. 2: A-22
21. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42-9
22. Wang WH, Huang JQ, Zheng GF, et al. Is proton pump inhibitor testing an effective approach to diagnose gastro-esophageal reflux disease in patients with noncardiac chest pain? a meta-analysis Arch Intern Med 2005; 165: 1222-8
23. Achem SR, Kolts BE, MacMath T, et al. Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci 1997; 42: 2138-45
24. Richter JE. Ear, nose and throat and respiratory manifestations of gastro-esophageal reflux disease: an increasing conundrum. Eur J Gastroenterol Hepatol 2004; 16: 837-45